Is a complete ASMB research report available?

No complete published report is available for Assembly Biosciences, Inc. (ASMB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Assembly Biosciences, Inc. (ASMB)

NASDAQ: ASMB · USD

$20.6

+0.25 (+1.2%)· Recorded snapshot

Market cap	418.4M
Revenue (ttm)	74.8M
Net income (ttm)	-42K
EPS (ttm)	-$0.00
Shares out	20.4M
Volume	109,451
Beta	1.16

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 74.8M
Net income (ttm): -42K
EPS (ttm): -$0.00
Market cap: 418.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Metric	Value
Amount currency	USD
CIK code	0001426800
Company name	Assembly Biosciences, Inc.
Country	United States
Country code	US
CUSIP number	045396207
Earnings date	2026-11-09
Earnings time	amc
Employees	73
Employees change	8
Employees growth	12.31%
Enterprise value	$100.4M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2005
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2010-12-17
Is primary listing	Yes
Is SPAC	No
ISIN number	US0453962070
Last 10-K release date	2026-03-19
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2024-02-12
Last stock split type	Reverse
Market cap	$418.4M
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$20.55
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ASMB
U.S. state	California
Website	https://www.assemblybio.com

Metric

Value

Amount currency

USD

CIK code

0001426800

Company name

Assembly Biosciences, Inc.

Country

United States

Country code

CUSIP number

045396207

Earnings date

2026-11-09

Earnings time

amc

Employees

Employees change

Employees growth

12.31%

Enterprise value

$100.4M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2005

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2010-12-17

Is primary listing

Yes

Is SPAC

ISIN number

US0453962070

Last 10-K release date

2026-03-19

Last earnings date

2026-08-13

Last refreshed

2026-10-28

Last stock split date

2024-02-12

Last stock split type

Reverse

Market cap

$418.4M

Market cap category

Small-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$20.55

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

ASMB

U.S. state

California

Website

https://www.assemblybio.com

Metric	Value
Adjusted P/E ratio	20.15x
Earnings yield	-0.01%
EV/Sales	1.33x
FCF / EV yield	-38.85%
FCF yield	-9.24%
Forward EV/Sales	1.83x
Forward P/S	7.68x
P/B ratio	1.32x
P/S ratio	5.58x
Price / tangible book value	1.37x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Adjusted P/E ratio

20.15x

Earnings yield

-0.01%

EV/Sales

1.33x

FCF / EV yield

-38.85%

FCF yield

-9.24%

Forward EV/Sales

1.83x

Forward P/S

7.68x

P/B ratio

1.32x

P/S ratio

5.58x

Price / tangible book value

1.37x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	-11.75%
EBITDA margin	-11.61%
Gross margin	14.95%
Operating margin	-11.75%
Pretax margin	-0.06%
Profit margin	-0.06%
Profit per employee	$-575
Revenue per employee	$1M
ROA	-2.67%
ROA (5Y)	-24.82%
ROCE	-2.86%
ROE	-0.03%
ROE (5Y)	-69.88%
ROIC	-3.34%
SBC / revenue	8.9%

Metric

Value

EBIT margin

-11.75%

EBITDA margin

-11.61%

Gross margin

14.95%

Operating margin

-11.75%

Pretax margin

-0.06%

Profit margin

-0.06%

Profit per employee

$-575

Revenue per employee

$1M

ROA

-2.67%

ROA (5Y)

-24.82%

ROCE

-2.86%

ROE

-0.03%

ROE (5Y)

-69.88%

ROIC

-3.34%

SBC / revenue

8.9%

Metric	Value
EPS growth quarters	15
EPS growth years	4
Net income growth quarters	1
Net income growth years	4
Revenue growth	125.12%
Revenue growth (Q)	38.94%
Revenue growth (QoQ)	62.84%
Revenue growth 5Y	15.99%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

125.12%

Revenue growth (Q)

38.94%

Revenue growth (QoQ)

62.84%

Revenue growth 5Y

15.99%

Revenue growth years

Metric	Value
Capital expenditures	$-85,000
Depreciation and amortization	$110,000
EBIT	$-8.8M
EBITDA	$-8.7M
EPS	$-0.00
FCF per share	$-1.89
Financing cash flow	$281.3M
Free cash flow	$-38.6M
Free cash flow minus SBC	$-45.2M
Gross profit	$11.2M
Investing cash flow	$-234.5M
Net cash flow	$8.3M
Net income	$-42,000
Operating cash flow minus SBC	$-45.1M
Operating income	$-8.8M
Revenue	$74.8M
Stock-based compensation	$6.7M

Metric

Value

Capital expenditures

$-85,000

Depreciation and amortization

$110,000

EBIT

$-8.8M

EBITDA

$-8.7M

EPS

$-0.00

FCF per share

$-1.89

Financing cash flow

$281.3M

Free cash flow

$-38.6M

Free cash flow minus SBC

$-45.2M

Gross profit

$11.2M

Investing cash flow

$-234.5M

Net cash flow

$8.3M

Net income

$-42,000

Operating cash flow minus SBC

$-45.1M

Operating income

$-8.8M

Revenue

$74.8M

Stock-based compensation

$6.7M

Metric	Value
Altman Z-Score	7.79
Book value per share	$15.40
Debt / equity	0.01
Long-term assets	$2.9M
Long-term liabilities	$1.7M
Net cash (debt)	$318M
Net cash / market cap	76.21%
Net cash growth	341.09%
Net debt / equity	-1.04
Piotroski F-Score	3
Property, plant and equipment	$2.5M
Shareholders' equity	$305.6M
Tangible book value	$305.6M
Tangible book value per share	$15.40
Total assets	$330.8M
Total cash	$320.4M
Total debt	$2.4M
Total liabilities	$25.2M
WACC	10.56%

Metric

Value

Altman Z-Score

7.79

Book value per share

$15.40

Debt / equity

0.01

Long-term assets

$2.9M

Long-term liabilities

$1.7M

Net cash (debt)

$318M

Net cash / market cap

76.21%

Net cash growth

341.09%

Net debt / equity

-1.04

Piotroski F-Score

Property, plant and equipment

$2.5M

Shareholders' equity

$305.6M

Tangible book value

$305.6M

Tangible book value per share

$15.40

Total assets

$330.8M

Total cash

$320.4M

Total debt

$2.4M

Total liabilities

$25.2M

WACC

10.56%

Metric	Value
Asset turnover	0.36
Current assets	$328M
Current liabilities	$23.4M
Current ratio	13.99
Net working capital	$-15.2M
Quick ratio	13.79
Working capital	$304.5M
Working capital turnover	0.45

Metric

Value

Asset turnover

0.36

Current assets

$328M

Current liabilities

$23.4M

Current ratio

13.99

Net working capital

$-15.2M

Quick ratio

13.79

Working capital

$304.5M

Working capital turnover

0.45

Metric	Value
Buyback yield / dilution	-133.27%
Dividend yield	0%
Shareholder yield	-133.27%

Metric

Value

Buyback yield / dilution

-133.27%

Dividend yield

Shareholder yield

-133.27%

Metric	Value
10Y price change	-87.9%
10Y return CAGR	-19.04%
10Y total return	-87.9%
150-day SMA	$27.03
15Y price change	-95.9%
15Y return CAGR	-19.18%
15Y total return	-95.9%
1D price change	1.23%
1M price change	-14.34%
1M total return	-14.34%
1W price change	-4.32%
1W total return	-4.32%
1Y price change	-31.96%
1Y return CAGR	-31.98%
1Y total return	-31.96%
20-day SMA	$21.31
200-day SMA	$27.31
3M price change	-21.75%
3M total return	-21.75%
3Y price change	107.01%
3Y return CAGR	27.44%
3Y total return	107.01%
50-day SMA	$26.66
50-day SMA vs 200-day SMA	50under200
52-week high	$39.71
52-week high date	2025-11-20
52-week low	$19.30
52-week low date	2026-10-23
5Y price change	-45.5%
5Y return CAGR	-11.43%
5Y total return	-45.5%
6M price change	-26.33%
6M total return	-26.33%
All-time high	$1,260.00
All-time high date	2011-05-05
All-time low	$7.69
All-time low date	2023-11-22
Average true range (ATR)	$1.11
Average volume	224.7K
Beta (1Y)	1
Beta (2Y)	1.41
Beta (5Y)	1.16
Change from 52-week high	-48.24%
Change from 52-week low	6.48%
Change from all-time high	-98.39%
Change from all-time low	163.59%
Change from open	1.23%
Day's gap	0%
Dollar volume	$2.2M
High price	$20.67
Low price	$20.22
Monthly RSI	45.49
Open price	$20.30
Position in 52-week range	73.33%
Premarket change	1.82%
Premarket close	$20.30
Premarket price	$20.67
Previous close	$20.30
Price vs 150-day SMA	-25%
Price vs 20-day SMA	-4.86%
Price vs 200-day SMA	-25.76%
Price vs 50-day SMA	-23.96%
Relative volume	0.49
RSI	34.81
Sharpe ratio	-0.43
Sharpe ratio (3Y)	0.59
Sharpe ratio (5Y)	0.08
Sortino ratio	-0.5
Sortino ratio (3Y)	0.99
Sortino ratio (5Y)	0.22
Volume	109.5K
Weekly RSI	37.7
YTD price change	-40.39%
YTD total return	-40.39%

Metric

Value

10Y price change

-87.9%

10Y return CAGR

-19.04%

10Y total return

-87.9%

150-day SMA

$27.03

15Y price change

-95.9%

15Y return CAGR

-19.18%

15Y total return

-95.9%

1D price change

1.23%

1M price change

-14.34%

1M total return

-14.34%

1W price change

-4.32%

1W total return

-4.32%

1Y price change

-31.96%

1Y return CAGR

-31.98%

1Y total return

-31.96%

20-day SMA

$21.31

200-day SMA

$27.31

3M price change

-21.75%

3M total return

-21.75%

3Y price change

107.01%

3Y return CAGR

27.44%

3Y total return

107.01%

50-day SMA

$26.66

50-day SMA vs 200-day SMA

50under200

52-week high

$39.71

52-week high date

2025-11-20

52-week low

$19.30

52-week low date

2026-10-23

5Y price change

-45.5%

5Y return CAGR

-11.43%

5Y total return

-45.5%

6M price change

-26.33%

6M total return

-26.33%

All-time high

$1,260.00

All-time high date

2011-05-05

All-time low

$7.69

All-time low date

2023-11-22

Average true range (ATR)

$1.11

Average volume

224.7K

Beta (1Y)

Beta (2Y)

1.41

Beta (5Y)

1.16

Change from 52-week high

-48.24%

Change from 52-week low

6.48%

Change from all-time high

-98.39%

Change from all-time low

163.59%

Change from open

1.23%

Day's gap

Dollar volume

$2.2M

High price

$20.67

Low price

$20.22

Monthly RSI

45.49

Open price

$20.30

Position in 52-week range

73.33%

Premarket change

1.82%

Premarket close

$20.30

Premarket price

$20.67

Previous close

$20.30

Price vs 150-day SMA

-25%

Price vs 20-day SMA

-4.86%

Price vs 200-day SMA

-25.76%

Price vs 50-day SMA

-23.96%

Relative volume

0.49

RSI

34.81

Sharpe ratio

-0.43

Sharpe ratio (3Y)

0.59

Sharpe ratio (5Y)

0.08

Sortino ratio

-0.5

Sortino ratio (3Y)

0.99

Sortino ratio (5Y)

0.22

Volume

109.5K

Weekly RSI

37.7

YTD price change

-40.39%

YTD total return

-40.39%

Metric	Value
Float	9.2M
Float percentage	45.06%
Shares change (QoQ)	11.56%
Shares change (YoY)	133.27%
Shares held by insiders	3.02%
Shares held by institutions	41.66%
Shares outstanding	20.4M
Short % of float	30.76%
Short % of shares	13.86%
Short ratio	7.6 days

Metric

Value

Float

9.2M

Float percentage

45.06%

Shares change (QoQ)

11.56%

Shares change (YoY)

133.27%

Shares held by insiders

3.02%

Shares held by institutions

41.66%

Shares outstanding

20.4M

Short % of float

30.76%

Short % of shares

13.86%

Short ratio

7.6 days

Assembly Biosciences, Inc. (ASMB)

Price

Financial snapshot

Fair-value bridge

Latest news · ASMB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASMB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASMB

Frequently asked questions